Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid vs Solid L-Thyroxine in Children with Hypothyroidism
NCT02917863Phase 4Unknown
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- May 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Meyer Children's Hospital IRCCS. Primary endpoints: Effects on gut inflammation parameter (Calprotectin) at 12 months, Effects on gut absorption parameters at 12 months and 2 more. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT02917863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02917863.